Form 4 for MNPR Monopar Therapeutics
Accepted 2026-01-30 00:00:00 ET · period of report 2025-01-28 · accession 0001437749-26-002527 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-01-30 | 2025-01-28 | MNPR | Robinson Chandler | CEO, Dir | J - Other | $0.00 | +62.8K | 62.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-28 | J | A | 62,815 | $0.00 | 62,815 | I See Footnote | — | — | (F2) Represents shares held by the Chandler D. Robinson Irrevocable Trust U/A dated May 20, 2020. |